The protective effects of naringenin, a citrus flavonoid, non-complexed or complexed with hydroxypropyl-β-cyclodextrin against multiorgan damage caused by neonatal endotoxemia.

Cytokines ERK1/2 Flavonoid Lipopolysaccharide Oxidative stress p38MAPK

Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
28 Feb 2024
Historique:
received: 30 09 2023
revised: 16 02 2024
accepted: 17 02 2024
medline: 2 3 2024
pubmed: 2 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

Endotoxemia is a severe and dangerous clinical syndrome that results in elevated morbidity, especially in intensive care units. Neonates are particularly susceptible to endotoxemia due to their immature immune systems. There are few effective treatments for neonatal endotoxemia. One group of compounds with potential in the treatment of neonatal inflammatory diseases such as endotoxemia is the flavonoids, mainly due to their antioxidant and anti-inflammatory properties. Among these, naringenin (NGN) is a citrus flavonoid which has already been reported to have anti-inflammatory, antioxidant, anti-nociceptive and anti-cancer effects. Unfortunately, its clinical application is limited by its low solubility and bioavailability. However, cyclodextrins (CDs) have been widely used to improve the solubility of nonpolar drugs and enhance the bioavailability of these natural products. We, therefore, aimed to investigate the effects of NGN non-complexed and complexed with hydroxypropyl-β-cyclodextrin (HPβCD) on neonatal endotoxemia injuries in a rodent model and describe the probable molecular mechanisms involved in NGN activities. We used exposure to a bacterial lipopolysaccharide (LPS) to induce neonatal endotoxemia in the mice. It was found that NGN (100 mg/kg i.p.) exposure during the neonatal period reduced leukocyte migration and decreased pro-inflammatory cytokine (TNF-α, IL-1β and IL-6) levels in the lungs, heart, kidneys or cerebral cortex. In addition, NGN upregulated IL-10 production in the lungs and kidneys of neonate mice. The administration of NGN also enhanced antioxidant enzyme catalase and SOD activity, reduced lipid peroxidation and protein carbonylation and increased the reduced sulfhydryl groups in an organ-dependent manner, attenuating the oxidative damage caused by LPS exposure. NGN decreased ERK1/2, p38MAPK and COX-2 activation in the lungs of neonate mice. Moreover, NGN complexed with HPβCD was able to increase the animal survival rate. NGN attenuated inflammatory and oxidative damage in the lungs, heart and kidneys caused by neonatal endotoxemia through the MAPK signaling pathways regulation. Our results show that NGN has beneficial effects against neonatal endotoxemia and could be useful in the treatment of neonatal inflammatory injuries.

Sections du résumé

BACKGROUND BACKGROUND
Endotoxemia is a severe and dangerous clinical syndrome that results in elevated morbidity, especially in intensive care units. Neonates are particularly susceptible to endotoxemia due to their immature immune systems. There are few effective treatments for neonatal endotoxemia. One group of compounds with potential in the treatment of neonatal inflammatory diseases such as endotoxemia is the flavonoids, mainly due to their antioxidant and anti-inflammatory properties. Among these, naringenin (NGN) is a citrus flavonoid which has already been reported to have anti-inflammatory, antioxidant, anti-nociceptive and anti-cancer effects. Unfortunately, its clinical application is limited by its low solubility and bioavailability. However, cyclodextrins (CDs) have been widely used to improve the solubility of nonpolar drugs and enhance the bioavailability of these natural products.
OBJECTIVE OBJECTIVE
We, therefore, aimed to investigate the effects of NGN non-complexed and complexed with hydroxypropyl-β-cyclodextrin (HPβCD) on neonatal endotoxemia injuries in a rodent model and describe the probable molecular mechanisms involved in NGN activities.
METHOD METHODS
We used exposure to a bacterial lipopolysaccharide (LPS) to induce neonatal endotoxemia in the mice.
RESULTS RESULTS
It was found that NGN (100 mg/kg i.p.) exposure during the neonatal period reduced leukocyte migration and decreased pro-inflammatory cytokine (TNF-α, IL-1β and IL-6) levels in the lungs, heart, kidneys or cerebral cortex. In addition, NGN upregulated IL-10 production in the lungs and kidneys of neonate mice. The administration of NGN also enhanced antioxidant enzyme catalase and SOD activity, reduced lipid peroxidation and protein carbonylation and increased the reduced sulfhydryl groups in an organ-dependent manner, attenuating the oxidative damage caused by LPS exposure. NGN decreased ERK1/2, p38MAPK and COX-2 activation in the lungs of neonate mice. Moreover, NGN complexed with HPβCD was able to increase the animal survival rate.
CONCLUSION CONCLUSIONS
NGN attenuated inflammatory and oxidative damage in the lungs, heart and kidneys caused by neonatal endotoxemia through the MAPK signaling pathways regulation. Our results show that NGN has beneficial effects against neonatal endotoxemia and could be useful in the treatment of neonatal inflammatory injuries.

Identifiants

pubmed: 38428770
pii: S0141-8130(24)01303-5
doi: 10.1016/j.ijbiomac.2024.130500
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

130500

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Luana Heimfarth (L)

Laboratory of Neuroscience and Pharmacological Assay (LANEF), Department of Physiology, Federal University of Sergipe, São Cristóvão, Sergipe CEP: 49100-000, Brazil.

Katielen Silvana Dos Santos (KS)

Laboratory of Neuroscience and Pharmacological Assay (LANEF), Department of Physiology, Federal University of Sergipe, São Cristóvão, Sergipe CEP: 49100-000, Brazil.

Brenda Souza Monteiro (BS)

Laboratory of Neuroscience and Pharmacological Assay (LANEF), Department of Physiology, Federal University of Sergipe, São Cristóvão, Sergipe CEP: 49100-000, Brazil.

Anne Karoline de Souza Oliveira (AK)

Laboratory of Neuroscience and Pharmacological Assay (LANEF), Department of Physiology, Federal University of Sergipe, São Cristóvão, Sergipe CEP: 49100-000, Brazil.

Henrique Douglas M Coutinho (HDM)

Universidade Regional do Cariri - URCA, Departmento de Química Biológica, Crato, CE, Brazil. Electronic address: hdmcoutinho@gmail.com.

Irwin R A Menezes (IRA)

Universidade Regional do Cariri - URCA, Departmento de Química Biológica, Crato, CE, Brazil.

Marcio Roberto Viana Dos Santos (MRV)

Graduate Program of Health Sciences, Federal University of Sergipe, Aracaju, Sergipe CEP 49060-025, Brazil.

Adriano Antunes de Souza Araújo (AA)

Graduate Program of Health Sciences, Federal University of Sergipe, Aracaju, Sergipe CEP 49060-025, Brazil.

Laurent Picot (L)

UMR CNRS 7266 LIENSs, La Rochelle Université, 17042 La Rochelle, France.

Raimundo Gonçalves de Oliveira Júnior (RG)

Laboratoire de Pharmacognosie-UMR CNRS 8638, Faculté de Pharmacie, Université Paris Cité, Paris, France.

Raphaël Grougnet (R)

Laboratoire de Pharmacognosie-UMR CNRS 8638, Faculté de Pharmacie, Université Paris Cité, Paris, France.

Jullyana de Souza Siqueira Quintans (J)

Laboratory of Neuroscience and Pharmacological Assay (LANEF), Department of Physiology, Federal University of Sergipe, São Cristóvão, Sergipe CEP: 49100-000, Brazil; Graduate Program of Health Sciences, Federal University of Sergipe, Aracaju, Sergipe CEP 49060-025, Brazil.

Lucindo José Quintans-Júnior (LJ)

Laboratory of Neuroscience and Pharmacological Assay (LANEF), Department of Physiology, Federal University of Sergipe, São Cristóvão, Sergipe CEP: 49100-000, Brazil; Graduate Program of Health Sciences, Federal University of Sergipe, Aracaju, Sergipe CEP 49060-025, Brazil.

Classifications MeSH